Nova Patents
AT254476T

88KDA tumorigenic growth factor and antagonists

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

100 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
86307997United States of AmericaA
99186297United States of AmericaA
9810555United States of AmericaW

Members100

Family members, oldest first
DocumentOfficeKind
CA2290602A1CanadaA1
WO9852607A1World Intellectual Property Organization (WIPO)A1
AU7797898AAustraliaA
EP1011723A1European Patent Office (EPO)A1
US6309826B1United States of AmericaB1
EP1011723A4European Patent Office (EPO)A4
US2002025543A1United States of AmericaA1
US2002061859A1United States of AmericaA1
US2002094966A1United States of AmericaA1
US2002183270A1United States of AmericaA1
CA2450590A1CanadaA1
CA2450666A1CanadaA1
WO02102229A2World Intellectual Property Organization (WIPO)A2
WO02102306A2World Intellectual Property Organization (WIPO)A2
US2003092661A1United States of AmericaA1
WO02102306A3World Intellectual Property Organization (WIPO)A3
US2003108950A1United States of AmericaA1
EP1356824A2European Patent Office (EPO)A2
WO02102229A3World Intellectual Property Organization (WIPO)A3
EP1011723B1European Patent Office (EPO)B1
US2003215445A1United States of AmericaA1
AT254476TThis recordAustriaT
ATE254476T1AustriaT1
DE69819911D1GermanyD1
US6670183B2United States of AmericaB2
EP1356824A3European Patent Office (EPO)A3
DK1011723T3DenmarkT3
EP1399739A2European Patent Office (EPO)A2
EP1404365A2European Patent Office (EPO)A2
US6720159B1United States of AmericaB1
PT1011723EPortugalE
SI1011723T1SloveniaT1
CA2504178A1CanadaA1
WO2004039244A2World Intellectual Property Organization (WIPO)A2
WO02102306A8World Intellectual Property Organization (WIPO)A8
KR20040043128ARepublic of KoreaA
AU2003284190A1AustraliaA1
US2004131618A1United States of AmericaA1
WO2004060280A2World Intellectual Property Organization (WIPO)A2
AU2003296432A1AustraliaA1
AU2003296432A8AustraliaA8
ES2213906T3SpainT3
DE69819911T2GermanyT2
US6824775B2United States of AmericaB2
US6881548B2United States of AmericaB2
WO2004039244A3World Intellectual Property Organization (WIPO)A3
JP2005514907AJapanA
WO2004060280A3World Intellectual Property Organization (WIPO)A3
EP1563308A2European Patent Office (EPO)A2
JP2005524602AJapanA
CN1682111AChinaA
JP2006504104AJapanA
EP1404365A4European Patent Office (EPO)A4
HK1083366A1Hong Kong, ChinaA1
EP1399739A4European Patent Office (EPO)A4
US7091047B2United States of AmericaB2
EP1563308A4European Patent Office (EPO)A4
AU2002315060B2AustraliaB2
AU2002312462B2AustraliaB2
CN100397081CChinaC
WO02102229A9World Intellectual Property Organization (WIPO)A9
JP4242836B2JapanB2
KR20090045423ARepublic of KoreaA
JP2009109489AJapanA
US2009203047A1United States of AmericaA1
US7592318B2United States of AmericaB2
JP2009215302AJapanA
JP4348178B2JapanB2
CN101584862AChinaA
JP4392238B2JapanB2
US2010021475A1United States of AmericaA1
US2010111928A1United States of AmericaA1
KR20100050580ARepublic of KoreaA
KR100972053B1Republic of KoreaB1
AU2003284190B2AustraliaB2
KR100980105B1Republic of KoreaB1
AU2010246504A1AustraliaA1
EP1404365B1European Patent Office (EPO)B1
AT496635TAustriaT
ATE496635T1AustriaT1
DE60239059D1GermanyD1
ES2359494T3SpainT3
US8007997B2United States of AmericaB2
JP4763032B2JapanB2
AU2010246504B2AustraliaB2
EP1563308B1European Patent Office (EPO)B1
AT529743TAustriaT
ATE529743T1AustriaT1
US2012087918A1United States of AmericaA1
ES2395125T3SpainT3
KR101258254B1Republic of KoreaB1
JP2013139473AJapanA
US8512960B2United States of AmericaB2
EP1399739B1European Patent Office (EPO)B1
US8911950B2United States of AmericaB2
ES2531368T3SpainT3
CA2290602CCanadaC
JP2015227369AJapanA
CN101584862BChinaB
CA2504178CCanadaC